PubMed · 11155588
Dapsone and sulfapyridine.
Abstract
Dapsone and sulfapyridine are structurally related compounds with anti-microbial and anti-inflammatory effects. Dapsone remains the most important drug for leprosy and is useful in the prophylaxis of Pneumocystis pneumonia in patients with HIV disease. The medical treatment of choice for dermatitis herpetiformis is dapsone; and sulfapyridine also can be used for those patients who are intolerant of dapsone. Other neutrophilic disorders also may respond to these drugs. Toxic side effects of both dapsone and sulfapyridine are mediated through the hydroxylamine metabolite. These include hemolysis, methemoglobinemia, and agranulocytosis. Careful monitoring for possible adverse reactions includes frequently performing complete blood counts and regular blood chemistry profile determinations.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
U Paniker, N Levine. 2001. Dapsone and sulfapyridine.. https://doi.org/10.1016/s0733-8635(05)70231-x. https://pubmed.health/record/pubmed%3A11155588/dapsone-and-sulfapyridine
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.